Brief: Index Pharmaceuticals Gets New Patent For Cobitolimod Granted In Europe

Flerie AB

13/07/2022 12:14

July 13 (Reuters) - InDex Pharmaceuticals Holding AB
 INDEX.ST :
    * INDEX PHARMACEUTICALS GETS NEW PATENT FOR COBITOLIMOD
GRANTED IN
EUROPE
    * NEW METHOD OF USE PATENT FOR DRUG CANDIDATE COBITOLIMOD
HAS BEEN
GRANTED BY EUROPEAN PATENT OFFICE (EPO).
    * PATENT PROVIDES ADDITIONAL PROTECTION FOR USE OF
COBITOLIMOD IN
TREATMENT OF INFLAMMATORY BOWEL DISEASE.
    * PATENT, WITH PATENT NUMBER 3947685, WILL PROVIDE AN
EXCLUSIVITY
PERIOD UNTIL AUGUST 2040, WITH POSSIBILITY OF UP TO 5 YEARS TERM
EXTENSION AFTER MARKET APPROVAL.

Source text for Eikon:  ID:nWkr1TKF4h 
Further company coverage:  INDEX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))